Objetivo
The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is imperative. It is known that β-amyloid (Aβ) peptide plays a central role in neurodegeneration. In AD brain, Aβ is released in a soluble form that progressively becomes insoluble forming aggregates; extracellular plaques mainly composed of Aβ are a hallmark of post-mortem brains. These premises strongly suggest brain Aβ as a possible target for therapy and diagnosis of AD. In addition, it is known that brain and blood Aβ pools are in equilibrium via the blood-brain-barrier (BBB). Accordingly, it has been reported that removal of blood Aβ may withdraw the excess of brain Aβ by a “sink” effect. Thus, blood Aβ is another potential target. The aim of this project is to utilize nanoparticles (NPs) specifically engineered for targeting brain Aβ, for the combined diagnosis and therapy (theranostics) of AD. NPs (liposomes, solid lipid NPs, polymeric-NPs) will be multiple-functionalized with: i) a large arsenal of molecules (specific lipids, antiamyloidogenic drugs, polyphenols, heteroaromatic compounds, unnatural peptides and peptidomimetics, antibodies) interacting with Aβ in all aggregation forms, ii) PET or MRI contrast agents detecting such interaction, iii) molecules stimulating BBB crossing via the transcytotic route. Several artificial and cellular models will be used to fine-tune such features and to improve NPs biocompatibility, non-immunogenicity, non-toxicity and physical stability. Eventually, absorption, distribution, metabolism and excretion will be studied using animal models of AD. Different routes (i.v. oral, nasal) and protocols (two-step, NPs cocktails, aerosols) of administration will be utilized to boost NPs brain delivery. The prediction is that NPs will detect, disaggregate and remove Aβ brain deposits. In any case, NPs will interact with blood Aβ, withdrawing the excess of brain peptide by a “sink” effect.
Ámbito científico
Palabras clave
Convocatoria de propuestas
FP7-NMP-2007-LARGE-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
20126 MILANO
Italia
Ver en el mapa
Participantes (18)
91405 ORSAY CEDEX
Ver en el mapa
845 Bratislava
Ver en el mapa
17177 Stockholm
Ver en el mapa
1105AZ Amsterdam
Ver en el mapa
2100 Goedoello
Ver en el mapa
20014 Turku
Ver en el mapa
10144 Torino
Ver en el mapa
265 04 Rio Patras
Ver en el mapa
2000 Antwerpen
Ver en el mapa
48940 Leioa
Ver en el mapa
LA1 4YW Lancaster
Ver en el mapa
20156 Milano
Ver en el mapa
2825 182 Caparica
Ver en el mapa
75252 PARIS
Ver en el mapa
93420 VILLEPINTE
Ver en el mapa
48008 BILBAO
Ver en el mapa
1165 Kobenhavn
Ver en el mapa
41013 Sevilla
Ver en el mapa